ES2132272T3 - Procedimiento para la determinacion de aductos de hemoglobina. - Google Patents

Procedimiento para la determinacion de aductos de hemoglobina.

Info

Publication number
ES2132272T3
ES2132272T3 ES94104399T ES94104399T ES2132272T3 ES 2132272 T3 ES2132272 T3 ES 2132272T3 ES 94104399 T ES94104399 T ES 94104399T ES 94104399 T ES94104399 T ES 94104399T ES 2132272 T3 ES2132272 T3 ES 2132272T3
Authority
ES
Spain
Prior art keywords
hemoglobin
determination
concentration
procedure
blood sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94104399T
Other languages
English (en)
Inventor
Kin-Fai Yip
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of ES2132272T3 publication Critical patent/ES2132272T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE PRESENTA UN METODO MEJORADO PARA DETERMINAR LA CONCENTRACION DE UN ADUCTO DE HEMOGLOBINA EN UNA MUESTRA DE SANGRE EN EL QUE SE SIGUEN LOS PASOS SIGUIENTES: ENSAYAR LA MUESTRA DE SANGRE PARA DETERMINAR LA CANTIDAD TOTAL DE HEMOGLOBINA, ENSAYAR LA MUESTRA DE SANGRE PARA DETERMINAR EL ADUCTO DE HEMOGLOBINA Y DIVIDIR LA CONCENTRACION DEL ADUCTO DE HEMOGLOBINA ENTRE LA CONCENTRACION DE HEMOGLOBINA TOTAL. LA MEJORA CONSISTE EN NORMALIZAR LA MEDIDA DEL ADUCTO DE HEMOGLOBINA A LA CANTIDAD TOTAL DE HEMOGLOBINA QUE SE ENCUENTRA EN LA MUESTRA DE SANGRE.
ES94104399T 1993-04-02 1994-03-21 Procedimiento para la determinacion de aductos de hemoglobina. Expired - Lifetime ES2132272T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4147193A 1993-04-02 1993-04-02
US08/077,546 US6043043A (en) 1993-04-02 1993-06-18 Method for the determination of hemoglobin adducts

Publications (1)

Publication Number Publication Date
ES2132272T3 true ES2132272T3 (es) 1999-08-16

Family

ID=26718171

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94104399T Expired - Lifetime ES2132272T3 (es) 1993-04-02 1994-03-21 Procedimiento para la determinacion de aductos de hemoglobina.

Country Status (9)

Country Link
US (1) US6043043A (es)
EP (1) EP0618449B1 (es)
JP (1) JP3331251B2 (es)
AT (1) ATE181599T1 (es)
DE (1) DE69419192T2 (es)
DK (1) DK0618449T3 (es)
ES (1) ES2132272T3 (es)
FI (1) FI109557B (es)
NZ (1) NZ260084A (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459127B2 (en) * 2002-02-26 2008-12-02 Siemens Healthcare Diagnostics Inc. Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces
CN102443159B (zh) * 2002-08-06 2015-04-08 梅塔博利克斯股份有限公司 聚合物的萃取方法
JP2005537487A (ja) * 2002-09-03 2005-12-08 ツェプトゼンス　アクチエンゲゼルシャフト 試料中において任意には分画された後の試料中において、固定化特異的結合パートナーとして測定される分析対象物を用いる分析プラットフォーム及び検出法
US7125711B2 (en) * 2002-12-19 2006-10-24 Bayer Healthcare Llc Method and apparatus for splitting of specimens into multiple channels of a microfluidic device
US7094354B2 (en) * 2002-12-19 2006-08-22 Bayer Healthcare Llc Method and apparatus for separation of particles in a microfluidic device
US7435381B2 (en) * 2003-05-29 2008-10-14 Siemens Healthcare Diagnostics Inc. Packaging of microfluidic devices
US20080257754A1 (en) * 2003-06-27 2008-10-23 Pugia Michael J Method and apparatus for entry of specimens into a microfluidic device
US20040265172A1 (en) * 2003-06-27 2004-12-30 Pugia Michael J. Method and apparatus for entry and storage of specimens into a microfluidic device
US20040265171A1 (en) * 2003-06-27 2004-12-30 Pugia Michael J. Method for uniform application of fluid into a reactive reagent area
US7347617B2 (en) * 2003-08-19 2008-03-25 Siemens Healthcare Diagnostics Inc. Mixing in microfluidic devices
ATE509275T1 (de) * 2003-09-23 2011-05-15 Epinex Diagnostic Inc Schnelltest für glykiertes albumin
US7150995B2 (en) * 2004-01-16 2006-12-19 Metrika, Inc. Methods and systems for point of care bodily fluid analysis
JP4957547B2 (ja) * 2005-04-14 2012-06-20 パナソニック株式会社 ヘモグロビン誘導体の測定方法、それに用いる試薬組成物、測定キット、分析デバイス、及び分析システム
ATE555386T1 (de) * 2007-10-30 2012-05-15 Panasonic Corp Verfahren zur messung von hämoglobin und hämoglobin-derivat sowie messkit
US8715942B2 (en) * 2007-11-20 2014-05-06 Siemens Healthcare Diagnostics Inc. Methods for the detection of glycated hemoglobin
US20100167306A1 (en) * 2008-12-26 2010-07-01 Henry John Smith Rapid test for glycated albumin in saliva
US8603828B2 (en) 2009-11-18 2013-12-10 Bio-Rad Laboratories, Inc. Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms
KR20190006955A (ko) * 2016-05-13 2019-01-21 에이껜 가가꾸 가부시끼가이샤 측정 대상 물질의 비교 대상 물질에 대한 비율을 구하는 방법, 프로그램, 기억 매체 및 장치
WO2020014012A1 (en) * 2018-07-13 2020-01-16 Siemens Healthcare Diagnostics Inc. Methods for detection of aberrant results caused by incomplete dispersion of immunoassay reagent
EP3923806B1 (en) * 2019-02-15 2024-01-10 Siemens Healthcare Diagnostics Inc. Calibrators and controls for the determination of the percentage of glycated hemoglobin in a patient's liquid test sample
WO2020236233A1 (en) * 2019-05-20 2020-11-26 Siemens Healthcare Diagnostics Inc. Methods for detecting aberrant results caused by incomplete delivery of a polyhapten reagent in immunoassays
WO2020264513A1 (en) * 2019-06-27 2020-12-30 Case Western Reserve University Compositions and methods for blood and anemia detection
CN121384845B (zh) * 2024-07-10 2026-07-24 中元汇吉生物技术股份有限公司 一种修正胶乳比浊法测试HbA1c值的方法及修正胶乳比浊法测试HbA1c值的装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4837170A (en) * 1986-01-20 1989-06-06 Otsuka Pharmaceutical Co., Ltd. Monoclonal antibody, measuring method of glucosylated protein by utilizing the monoclonal antibody, and kit therefor
US4835097A (en) * 1986-10-15 1989-05-30 Saunders Alexander M Method for ascertaining the history of a condition of the body from a single blood sample
US4970171A (en) * 1987-11-09 1990-11-13 Miles Inc. Denaturant reagents for convenient determination of hemoglobin derivatives in blood

Also Published As

Publication number Publication date
JP3331251B2 (ja) 2002-10-07
ATE181599T1 (de) 1999-07-15
DK0618449T3 (da) 1999-12-06
NZ260084A (en) 1995-02-24
US6043043A (en) 2000-03-28
FI941522A0 (fi) 1994-03-31
FI109557B (fi) 2002-08-30
DE69419192T2 (de) 1999-11-04
FI941522L (fi) 1994-10-03
EP0618449A1 (en) 1994-10-05
JPH06308122A (ja) 1994-11-04
DE69419192D1 (de) 1999-07-29
EP0618449B1 (en) 1999-06-23

Similar Documents

Publication Publication Date Title
DE69920940D1 (de) Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte
ES2116578T3 (es) Procedimiento y dispositivo para evaluar la aptitud de biopolimeros.
AR027346A1 (es) Tira de analisis reactiva para la determinacion de analitos
ES2040735T3 (es) Soporte de ensayo para la determinacion analitica de constituyentes de liquidos corporales.
ES2141073T1 (es) Nuevos reactivos y metodo de lisis de eritrocitos.
NO954897L (no) Fremgangsmåte for å bestemme et individs inflammasjonsindeks fra hele blodfibrinogen og hematokrit eller hemoglobinmålinger
ES2061459T3 (es) Procedimiento de ensayo de substancias fisiologicamente activas.
ES2051303T3 (es) Dispositivo de ensayo con puertas multiples.
SE8404895D0 (sv) Medel och sett for ett overkenslighetstest
ES2058164T3 (es) Conjugados fluorescentes y ensayo de diagnostico biologico.
FI941522A0 (fi) Menetelmä hemoglobiiniadditiotuotteiden määrittämiseksi
NO840769L (no) Proevetager for anvendelse ved paavisning av okkult blod, samt fremgangsmaate for slik paavisning
NO953770L (no) Analysemetode
ES2175453T3 (es) Procedimiento de diagnostico para la alterosclerosis.
EA199800493A1 (ru) Анализ крови на соотношение активности фактора v для оценки вероятности заболевания тромбоэмболией
ES2164761T3 (es) Cubeta de un analizador, y metodo y kit de ensayo de diagnostico para la determinacion de analitos en muestras de sangre completa.
DE68921486D1 (de) Regelungsverfahren und -anordnung für die lumineszenz oder fluoreszenz.
PT1003458E (pt) Teste de funcao hepatica
ES2172287T3 (es) Metodos de deteccion y tratamiento de individuos con celulas anormales que expresan los antigenos peptidicos hla-a2/tirosinasa.
Kirstein et al. Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosis
AR220329A1 (es) Composicion de ensayo para determinar la presencia de sangre o peroxidasa en una muestra de ensayo,dispositivo que la comprende y procedimiento para preparar el dispositivo
ES2162037T3 (es) Procedimiento de analisis espectroscopico de muestras no homogeneas.
ES2090492T3 (es) Determinacion de analitos de peso molecular elevado.
ES2163158T3 (es) Medicion no invasiva del ph sanguineo.
EP0600087A4 (en) Method and kit of in vitro irritation test.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 618449

Country of ref document: ES